Hollsteen
← Adobe

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $7.1B · 10-Q 0000796343-16-000290 filed Mar 30, 2016Equity incl. NCI · Q2 FY2016: $7.2B · 10-Q 0000796343-16-000352 filed Jun 29, 2016Equity incl. NCI · Q3 FY2016: $7.3B · 10-Q 0000796343-16-000395 filed Sep 27, 2016Equity incl. NCI · Q4 FY2016: $7.4B · 10-K 0000796343-17-000031 filed Jan 20, 2017Equity incl. NCI · Q1 FY2017: $7.6B · 10-Q 0000796343-17-000088 filed Mar 29, 2017Equity incl. NCI · Q2 FY2017: $7.8B · 10-Q 0000796343-17-000130 filed Jun 28, 2017Equity incl. NCI · Q3 FY2017: $8.2B · 10-Q 0000796343-17-000157 filed Sep 27, 2017Equity incl. NCI · Q4 FY2017: $8.5B · 10-K 0000796343-18-000015 filed Jan 22, 2018Equity incl. NCI · Q1 FY2018: $8.6B · 10-Q 0000796343-18-000065 filed Mar 28, 2018Equity incl. NCI · Q2 FY2018: $8.7B · 10-Q 0000796343-18-000134 filed Jun 27, 2018Equity incl. NCI · Q3 FY2018: $8.9B · 10-Q 0000796343-18-000160 filed Sep 26, 2018Equity incl. NCI · Q4 FY2018: $9.4B · 10-K 0000796343-19-000019 filed Jan 25, 2019Equity incl. NCI · Q1 FY2019: $9.9B · 10-Q 0000796343-19-000079 filed Mar 27, 2019Equity incl. NCI · Q2 FY2019: $9.9B · 10-Q 0000796343-19-000142 filed Jun 26, 2019Equity incl. NCI · Q3 FY2019: $10.2B · 10-Q 0000796343-19-000165 filed Sep 26, 2019Equity incl. NCI · Q4 FY2019: $10.5B · 10-K 0000796343-20-000013 filed Jan 21, 2020Equity incl. NCI · Q1 FY2020: $10.5B · 10-Q 0000796343-20-000064 filed Mar 25, 2020Equity incl. NCI · Q2 FY2020: $10.9B · 10-Q 0000796343-20-000143 filed Jun 24, 2020Equity incl. NCI · Q3 FY2020: $11.7B · 10-Q 0000796343-20-000201 filed Sep 23, 2020Equity incl. NCI · Q4 FY2020: $13.3B · 10-K 0000796343-21-000004 filed Jan 15, 2021Equity incl. NCI · Q1 FY2021: $13.5B · 10-Q 0000796343-21-000069 filed Mar 31, 2021Equity incl. NCI · Q2 FY2021: $13.9B · 10-Q 0000796343-21-000159 filed Jun 30, 2021Equity incl. NCI · Q3 FY2021: $14.4B · 10-Q 0000796343-21-000210 filed Sep 29, 2021Equity incl. NCI · Q4 FY2021: $14.8B · 10-K 0000796343-22-000032 filed Jan 21, 2022Equity incl. NCI · Q1 FY2022: $13.8B · 10-Q 0000796343-22-000099 filed Mar 30, 2022Equity incl. NCI · Q2 FY2022: $14.0B · 10-Q 0000796343-22-000157 filed Jun 29, 2022Equity incl. NCI · Q3 FY2022: $14.4B · 10-Q 0000796343-22-000196 filed Sep 28, 2022Equity incl. NCI · Q4 FY2022: $14.1B · 10-K 0000796343-23-000007 filed Jan 17, 2023Equity incl. NCI · Q1 FY2023: $14.2B · 10-Q 0000796343-23-000055 filed Mar 29, 2023Equity incl. NCI · Q2 FY2023: $14.8B · 10-Q 0000796343-23-000153 filed Jun 28, 2023Equity incl. NCI · Q3 FY2023: $15.8B · 10-Q 0000796343-23-000205 filed Sep 27, 2023Equity incl. NCI · Q4 FY2023: $16.5B · 10-K 0000796343-24-000006 filed Jan 17, 2024Equity incl. NCI · Q1 FY2024: $15.5B · 10-Q 0000796343-24-000065 filed Mar 27, 2024Equity incl. NCI · Q2 FY2024: $14.8B · 10-Q 0000796343-24-000150 filed Jun 26, 2024Equity incl. NCI · Q3 FY2024: $14.5B · 10-Q 0000796343-24-000208 filed Sep 25, 2024Equity incl. NCI · Q4 FY2024: $14.1B · 10-K 0000796343-25-000004 filed Jan 13, 2025Equity incl. NCI · Q1 FY2025: $13.1B · 10-Q 0000796343-25-000059 filed Mar 26, 2025Equity incl. NCI · Q2 FY2025: $11.4B · 10-Q 0000796343-25-000073 filed Jun 25, 2025Equity incl. NCI · Q3 FY2025: $11.8B · 10-Q 0000796343-25-000107 filed Sep 24, 2025Equity incl. NCI · Q4 FY2025: $11.6B · 10-K 0000796343-26-000003 filed Jan 15, 2026Equity incl. NCI · Q1 FY2026: $11.4B · 10-Q 0000796343-26-000056 filed Mar 25, 2026Equity incl. NCI · Q2 FY2026: $11.5B · 10-Q 0000796343-26-000112 filed Jun 15, 2026Equity incl. NCI · Q3 FY2026: $11.8B · 10-Q 0000796343-26-000156 filed Sep 22, 202610.211.87.116.5Q1 FY2016Q3 FY2026Q3 FY2019
$BEquity incl. NCI · Q3 FY2018: $8.9B · 10-Q 0000796343-18-000160 filed Sep 26, 2018Equity incl. NCI · Q4 FY2018: $9.4B · 10-K 0000796343-19-000019 filed Jan 25, 2019Equity incl. NCI · Q1 FY2019: $9.9B · 10-Q 0000796343-19-000079 filed Mar 27, 2019Equity incl. NCI · Q2 FY2019: $9.9B · 10-Q 0000796343-19-000142 filed Jun 26, 2019Equity incl. NCI · Q3 FY2019: $10.2B · 10-Q 0000796343-19-000165 filed Sep 26, 2019Equity incl. NCI · Q4 FY2019: $10.5B · 10-K 0000796343-20-000013 filed Jan 21, 2020Equity incl. NCI · Q1 FY2020: $10.5B · 10-Q 0000796343-20-000064 filed Mar 25, 2020Equity incl. NCI · Q2 FY2020: $10.9B · 10-Q 0000796343-20-000143 filed Jun 24, 202010.210.98.9Q3 FY2018Q2 FY2020Q3 FY2019
Q3 FY2019
10.2$B
All values (43)
PeriodValue ($B)Status
Q3 FY202611.8reported
Q2 FY202611.5reported
Q1 FY202611.4reported
Q4 FY202511.6reported
Q3 FY202511.8reported
Q2 FY202511.4reported
Q1 FY202513.1reported
Q4 FY202414.1reported
Q3 FY202414.5reported
Q2 FY202414.8reported
Q1 FY202415.5reported
Q4 FY202316.5reported
Q3 FY202315.8reported
Q2 FY202314.8reported
Q1 FY202314.2reported
Q4 FY202214.1reported
Q3 FY202214.4reported
Q2 FY202214.0reported
Q1 FY202213.8reported
Q4 FY202114.8reported
Q3 FY202114.4reported
Q2 FY202113.9reported
Q1 FY202113.5reported
Q4 FY202013.3reported
Q3 FY202011.7reported
Q2 FY202010.9reported
Q1 FY202010.5reported
Q4 FY201910.5reported
Q3 FY201910.2reported
Q2 FY20199.9reported
Q1 FY20199.9reported
Q4 FY20189.4reported
Q3 FY20188.9reported
Q2 FY20188.7reported
Q1 FY20188.6reported
Q4 FY20178.5reported
Q3 FY20178.2reported
Q2 FY20177.8reported
Q1 FY20177.6reported
Q4 FY20167.4reported
Q3 FY20167.3reported
Q2 FY20167.2reported
Q1 FY20167.1reported

CSV with all sources · Technical ID: equity_total

More metrics for Adobe

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$10.2B
Period
Q3 FY2019, ended Aug 30, 2019 · as of Aug 30, 2019 (balance as of date, not a sum)
Source
10-Q, filed Sep 26, 2019 · 0000796343-19-000165
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$10.2BSep 26, 201910-Q 0000796343-19-000165reported · confidence 1. · current